| 000 | 01909 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250512003015.0 | ||
| 264 | 0 | _c19900201 | |
| 008 | 199002s 0 0 eng d | ||
| 022 | _a0080-0015 | ||
| 024 | 7 |
_a10.1007/978-3-642-83781-4_23 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLemerle, J | |
| 245 | 0 | 0 |
_aHodgkin's disease in children: adaptation of treatment to risk factors. _h[electronic resource] |
| 260 |
_bRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer _c1989 |
||
| 300 |
_a214-21 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCombined Modality Therapy _xadverse effects |
| 650 | 0 | 4 |
_aDacarbazine _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHodgkin Disease _xradiotherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMechlorethamine _xadministration & dosage |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 |
_aProcarbazine _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aVinblastine |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aOberlin, O | |
| 700 | 1 | _aSchaison, G | |
| 700 | 1 | _aLeverger, G | |
| 700 | 1 | _aOlive, D | |
| 700 | 1 | _aBonnet, M | |
| 700 | 1 | _aDufillot, D | |
| 700 | 1 | _ade Lumley, L | |
| 773 | 0 |
_tRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer _gvol. 117 _gp. 214-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-642-83781-4_23 _zAvailable from publisher's website |
| 999 |
_c2487334 _d2487334 |
||